Traveler’s Diarrhea - 13/09/12
Corresponding author.Résumé |
Travelers’ diarrhea (TD) is the most important health issue among international travelers. In high risk areas, 50–90% of travelers may experience an episode of TD. The risk of acquiring TD is influenced by factors such as the destination, duration of stay, standard of accommodation, type of travel, age of the traveler, and also by individual risk factors. Most cases of TD are caused by bacteria; treatment for TD are loperamide and antibiotics. Preventive strategies such as hygiene measures have limited impact. Prophylactic intake of antibiotics or vaccines to prevent from TD can be considered in special situations.
Le texte complet de cet article est disponible en PDF.Keywords : Traveler’s diarrhea, Enterotoxigenic Escherichia coli, Vaccination, Prophylaxis
Plan
| Financial disclosure/conflict of interest: HK received research grants, fees for giving lectures and consultancy, as well as support for attending advisory boards and international conferences from Baxter and Novartis. MPK has received fees for speaking and consultancy, and support for advisory boards and attending international conferences from Novartis, GSK, and Pfizer. UW received research grants from Baxter and Nestlé and attended advisory boards organized by Novartis, Pfizer, and GSK. |
Vol 26 - N° 3
P. 691-706 - septembre 2012 Retour au numéro
Article précédent
- Travel-Associated Skin Disease
- Rachael Morris-Jones, Stephen Morris-Jones
- Environmental Hazards, Hot, Cold, Altitude, and Sun
- Sundeep Dhillon
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?